Recent advances in, and challenges of, designing OMA1 drug screens.
Pharmacol Res
; 176: 106063, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34999225
Key words
AZD1080 (PubChem CID: 135564570); CCCP (PubChem CID: 2603); Cancer; Ceritinib (PubChem CID: 57379345); Drug discovery; MG132 (PubChem CID: 462382); Membrane proteases; Mitochondria; Neurodegeneration; Protease inhibitors; SB216763 (PubChem CID: 176158); Sorafenib (PubChem CID: 216239); Tamoxifen (PubChem CID: 2733526); Valinomycin (PubChem CID: 3000706)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Metalloendopeptidases
Limits:
Animals
/
Humans
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2022
Document type:
Article